{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:46:02Z","timestamp":1782499562552,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Signal Processing and Control"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bspc.2026.110858","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:37:04Z","timestamp":1781926624000},"page":"110858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Decoding the heterogeneous landscape of cuproptosis-related genes in triple-negative breast cancer through integrated bulk and single-cell transcriptomic analysis"],"prefix":"10.1016","volume":"126","author":[{"given":"Jiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanlin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bspc.2026.110858_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"10087","key":"10.1016\/j.bspc.2026.110858_b0010","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bspc.2026.110858_b0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jconrel.2022.12.056","article-title":"Effect of cellular and microenvironmental multidrug resistance on tumor-targeted drug delivery in triple-negative breast cancer","volume":"354","author":"Tezcan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bspc.2026.110858_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101288","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"key":"10.1016\/j.bspc.2026.110858_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40364-024-00714-6","article-title":"Tumor microenvironment and immunotherapy for triple-negative breast cancer","volume":"12","author":"Guo","year":"2024","journal-title":"Biomarker Res."},{"issue":"17","key":"10.1016\/j.bspc.2026.110858_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells14171353","article-title":"The role of tumor microenvironment in triple-negative breast cancer and its therapeutic targeting","volume":"14","author":"Vuletic","year":"2025","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bspc.2026.110858_b0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/0008-5472.CAN-15-2478","article-title":"EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape","volume":"76","author":"Lim","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bspc.2026.110858_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107876","article-title":"Immune checkpoint inhibitors for triple-negative breast cancer: from immunological mechanisms to clinical evidence","volume":"98","author":"Farshbafnadi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bspc.2026.110858_b0050","article-title":"Chemotherapy-induced immunogenic cell death in combination with ICIs: a brief review of mechanisms, clinical insights, and therapeutic implications","volume":"16","author":"Li","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.bspc.2026.110858_b0055","doi-asserted-by":"crossref","first-page":"15864","DOI":"10.1021\/acsnano.4c02947","article-title":"Celecoxib augments paclitaxel-induced immunogenic cell death in triple-negative breast cancer","volume":"18","author":"Qian","year":"2024","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bspc.2026.110858_b0060","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70478","article-title":"Radiation-induced biological effects: molecular and cellular mechanism, and applications to radiation\/nuclear emergency and cancer therapy","volume":"6","author":"Hu","year":"2025","journal-title":"MedComm"},{"issue":"24","key":"10.1016\/j.bspc.2026.110858_b0065","article-title":"Coupling mitochondrial homeostasis to oxi-inflamm-aging network disruption via peptide-functionalized nanocomposite hydrogel for osteoarthritis intervention","volume":"38","author":"Zhang","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bspc.2026.110858_b0070","article-title":"Prospects of immunotherapy for triple-negative breast cancer","volume":"11","author":"Qiu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bspc.2026.110858_b0075","doi-asserted-by":"crossref","unstructured":"P. Tsvetkov, S. Coy, B. Petrova, M. Dreishpoon, A. Verma, M. Abdusamad, J. Rossen, L. Joesch-Cohen, R. Humeidi, R.D. Spangler, J.K. Eaton, E. Frenkel, M. Kocak, S.M. Corsello, S. Lutsenko, N. Kanarek, S. Santagata, T.R. Golub, Copper induces cell death by targeting lipoylated TCA cycle proteins, Science (New York, N.Y.) 375(6586) (2022) 1254-1261.","DOI":"10.1126\/science.abf0529"},{"issue":"10","key":"10.1016\/j.bspc.2026.110858_b0080","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1002\/mco2.724","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"5","author":"Yang","year":"2024","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12943-025-02445-0","article-title":"Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis","volume":"24","author":"Jing","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.bspc.2026.110858_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086945","article-title":"Therapeutic potential of tumor metabolic reprogramming in triple-negative breast cancer","volume":"24","author":"Munk\u00e1csy","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.bspc.2026.110858_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35404","article-title":"A pan-cancer cuproptosis signature predicting immunotherapy response and prognosis","volume":"10","author":"Zhu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bspc.2026.110858_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1022236","article-title":"Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0105","doi-asserted-by":"crossref","first-page":"18390","DOI":"10.1038\/s41598-023-45761-5","article-title":"Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer","volume":"13","author":"Wu","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bspc.2026.110858_b0110","doi-asserted-by":"crossref","first-page":"44091","DOI":"10.31083\/FBL44091","article-title":"Extended insights into advancing multi-omics and prognostic methods for cancer prognosis forecasting","volume":"30","author":"Xie","year":"2025","journal-title":"Front. Biosci. (Landmark Edition)"},{"key":"10.1016\/j.bspc.2026.110858_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.963220","article-title":"Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bspc.2026.110858_b0120","doi-asserted-by":"crossref","unstructured":"Z. Sun, H. Xu, G. Lu, C. Yang, X. Gao, J. Zhang, X. Liu, Y. Chen, K. Wang, J. Guo, J. Li, AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer, Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) 12(17) (2025) e2408106.","DOI":"10.1002\/advs.202408106"},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0125","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2421578","article-title":"DLAT promotes triple-negative breast cancer progression via YAP1 activation","volume":"25","author":"Liu","year":"2024","journal-title":"Cancer Biol. Ther."},{"issue":"24","key":"10.1016\/j.bspc.2026.110858_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70498","article-title":"Roles of copper transport systems members in breast cancer","volume":"13","author":"Chen","year":"2024","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.bspc.2026.110858_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00432-025-06191-0","article-title":"Single-cell RNA sequencing reveals SLC31A1-mediated M2 polarization of macrophages promotes malignant progression in triple-negative breast cancer","volume":"151","author":"Zhang","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bspc.2026.110858_b0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/EBC20160069","article-title":"Native and engineered sensors for Ca(2+) and Zn(2+): lessons from calmodulin and MTF1","volume":"61","author":"Carpenter","year":"2017","journal-title":"Essays Biochem."},{"issue":"10","key":"10.1016\/j.bspc.2026.110858_b0145","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1096\/fj.03-1282com","article-title":"Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver","volume":"18","author":"Wang","year":"2004","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010127","article-title":"Bioinformatics prediction and experimental validation identify a novel cuproptosis-related gene signature in human synovial inflammation during osteoarthritis progression","volume":"13","author":"Wang","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bspc.2026.110858_b0155","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1002\/mco2.502","article-title":"Multi-omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple-negative breast cancer","volume":"5","author":"Xie","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.bspc.2026.110858_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106936","article-title":"Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery","volume":"107","author":"Zou","year":"2022","journal-title":"Int. J. Surg. (London, England)"},{"issue":"2","key":"10.1016\/j.bspc.2026.110858_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020369","article-title":"Breaking barriers: the promise and challenges of immune checkpoint inhibitors in triple-negative breast cancer","volume":"12","author":"Said","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bspc.2026.110858_b0170","first-page":"0915","article-title":"Gene signature-based drug screening reveals ponatinib enhances immunotherapy efficacy in triple-negative breast cancer by reversing MDSC-mediated immunosuppressive tumor microenvironment","volume":"8","author":"Wang","year":"2025","journal-title":"Research (Washington D.C.)"},{"key":"10.1016\/j.bspc.2026.110858_b0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semcancer.2025.05.010","article-title":"T-cell senescence: Unlocking the tumor immune \u201cDark Box\u201d - a multidimensional analysis from mechanism to tumor immunotherapeutic intervention","volume":"113","author":"Cheng","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bspc.2026.110858_b0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00018-024-05454-2","article-title":"NPRL2 promotes TRIM16-mediated ubiquitination degradation of Galectin-3 to prevent CD8(+)T lymphocyte cuproptosis in glioma","volume":"81","author":"Wang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bspc.2026.110858_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111239","article-title":"Cuproptosis in microsatellite stable colon cancer cells affects the cytotoxicity of CD8(+)T through the WNT signaling pathway","volume":"403","author":"Zeng","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.bspc.2026.110858_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050632","article-title":"CD99: a key regulator in immune response and tumor microenvironment","volume":"15","author":"Manara","year":"2025","journal-title":"Biomolecules"}],"container-title":["Biomedical Signal Processing and Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1746809426014126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1746809426014126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:48:18Z","timestamp":1782496098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1746809426014126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"alternative-id":["S1746809426014126"],"URL":"https:\/\/doi.org\/10.1016\/j.bspc.2026.110858","relation":{},"ISSN":["1746-8094"],"issn-type":[{"value":"1746-8094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the heterogeneous landscape of cuproptosis-related genes in triple-negative breast cancer through integrated bulk and single-cell transcriptomic analysis","name":"articletitle","label":"Article Title"},{"value":"Biomedical Signal Processing and Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bspc.2026.110858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110858"}}